Kaku igaku. The Japanese journal of nuclear medicine
Guidelines for radio-iodine (131I) therapy in Graves' disease and thyroid cancer
Abstract
Radio-iodine (131I) therapy has been using in Graves' disease and well differentiated thyroid cancer. The rules of control in the discharge from radio-isotope hospital were notified in 1999 in Japan. Guideline of the 131I therapy in Graves' disease and thyroid cancer were prepared by sub-group of Japanese Society of Nuclear Medicine.
Source and rights
Published by Kaku igaku. The Japanese journal of nuclear medicine, 2005. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2005
- Applies to
- 🇯🇵 Japan
- Scope
- National
- Journal
- Kaku igaku. The Japanese journal of nuclear medicine
- PubMed
- 15794118
- Added to Prognia
- 23 July 2026
